4/A

OWNERSHIP DOCUMENT

Company: Zenas BioPharma, Inc.
Filed: September 17, 2024
Period of Report: September 12, 2024
Accession Number: 0001104659-24-100766

View Document ↗ View on SEC.gov ↗